Form 4: Kenvue Inc. Executive Awarded Stock Options and Restricted Stock Units
SEC Form 4 Filing
Caroline Tillett, Chief Scientific Officer of Kenvue Inc., received stock options and restricted stock units on March 10, 2025.
Summary
- Caroline Tillett, the Chief Scientific Officer of Kenvue Inc., was granted stock options and restricted stock units on March 10, 2025.
- The stock options grant consists of 81,837 shares with an exercise price of $23.92, expiring on March 10, 2035.
- Additionally, 9,807 restricted stock units were awarded, vesting in three equal installments on March 10, 2026, March 10, 2027, and March 10, 2028, contingent upon continued service.
- Following these transactions, Ms. Tillett directly owns 81,837 stock options and 9,807 restricted stock units.
Sentiment
Score: 7
Explanation: The document reflects a standard executive compensation practice, which is generally viewed neutrally to positively as it incentivizes management. The sentiment is moderately positive.
Positives
- The grant of stock options and restricted stock units aligns the executive's interests with those of the shareholders.
- The vesting schedule encourages long-term commitment from the Chief Scientific Officer.
Future Outlook
The vesting of the restricted stock units is contingent upon the reporting person's continued service.
Industry Context
Executive compensation packages often include stock options and restricted stock units to incentivize performance and align management's interests with shareholders.
Comparison to Industry Standards
- Stock option grants are a common component of executive compensation packages in publicly traded companies like Kenvue.
- The vesting schedule of the restricted stock units is typical, designed to retain key personnel over a multi-year period.
- Comparing the size of the grant to similar roles at comparable companies (e.g., Unilever, P&G) would provide further context on its competitiveness.
Stakeholder Impact
- Shareholders may view the grant positively as it aligns executive interests with company performance.
- Employees may see it as a sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 03/10/2025 | Date of the transaction (grant of stock options and restricted stock units). |
| 03/10/2026 | First vesting date for the restricted stock units. |
| 03/10/2027 | Second vesting date for the restricted stock units. |
| 03/10/2028 | Third vesting date for the restricted stock units. |
| 03/10/2035 | Expiration date for the stock options. |
| 03/12/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.